Emma Shiffman is a Research Coordinator at the Access to Medicine Foundation. She currently supports the Diabetes Care Programme and the Foundation’s work to mobilise generic and biosimilar medicine manufacturers. In this role, she contributes to research, planning, and coordination across internal teams and with the Foundation’s external stakeholder network. Previously, Emma was the Research Coordinator for the Access to Medicine Index, where her analysis focused on capacity building, inclusive business models, and local manufacturing efforts among large, R&D-based pharmaceutical companies.
Emma holds a Master's degree in Epidemiology from Utrecht University, where she specialised in Clinical Epidemiology. Her research included a study on early neurolinguistic risk factors for Alzheimer's disease, as well as a second project analysing depressive symptoms across different ethnic groups in Amsterdam before and during the COVID-19 pandemic.
Prior to joining the Foundation, Emma worked as a communications advisor for Health Action International, supporting its snakebite envenoming and sexual and reproductive health programmes.